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john W. Rebuck, MD, PhD 
Dr. John W. Rebuck is one of those rare individuals who 
can endear himself quickly and forever to his colleagues. 
Within this issue you wi l l find a brief biographical sketch, 
several reprints that are classic examples of his scientific 
research, and selected original articles by those who have 
known him through the years as a student or otherwise 
have been allied with him through common scientific 
interests. The Editorial Board o f the Henry Ford Hospital 
Medical Journal wishes to honor this unusual man, who 
has been the Editor of the Journal since 1972. All too often 
such an individual is commended for his contributions to 
science long after leaving the institution where he devoted 
his entire life. 
The Editorial Board believes this issue is justified for those 
who have been influenced by him in the past, continue to 
be now, and wil l be in the future because of his many 
achievements as a man and as a scientist. To those of us 
who have enjoyed having him "right at our elbow" over 
the years, this issue serves to recognize a colleague who 
has contributed importantly to medicine not just within 
Henry Ford Hospital but nationally and internationally as 
well . 
— Gilbert B. Bluhm, MD 
Guest Editor 
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John W. Rebuck's accomplishments as a physician and a 
scientist are so numerous that it is not possible to describe 
them fully. A native of Minnesota, he began his dis-
tinguished career at the University of Minnesota where he 
received his MD (1943) and his PhD (1947). While there, 
his interest in hematology was stimulated by his work with 
Hal Downey, considered by most to be the father of 
American hematology. During World War II, he was a 
Captain in the U.S. Medical Corps and served as a hema-
topathologist with the Armed Forces Institute of Pathology 
until 1947. 
At this time, John began his long career at Henry Ford 
Hospital in Detroit. He had interned at the Hospital in 1943 
and returned in 1947 to become Chief of the Division of 
Laboratory Hematology. The time, the place, and the man 
all proved propitious for the future of science. The elder 
Henry Ford had just bought a transmission electron micro-
scope for the Department of Pathology. Only a few such 
microscopes were then available anywhere in the country 
and, thanks to Henry Ford, the Hospital had one of the first 
RCA instruments in use in a private institution. Although 
Wol pers and Ruska had used the transmission electron 
microscope in Germany just before the outbreak of World 
War II, Rebuck and his colleagues were the first to use it to 
study the ultrastructure of leukocytes and erythrocytes. By 
1948, Rebuck had worked out a method for studying the 
sequence by which the red cells in sickle cell disease, so 
prevalent in the Detroit communi ty, underwent their 
bizarre transformation from an apparently normal bicon-
cave disc to the peculiar crescent shape that gives the 
disease its name. 
One fall afternoon in 1949, Linus Pauling came to Detroit 
to lecture on his newly discovered biochemical molecular 
lesion in sickle cell hemoglobin, pinpointing a change in 
its electrophoretic mobility, a discovery that would later 
win him the Nobel Prize. After listening to Pauling lecture 
on his discovery, John invited him to the EM laboratory to 
show him the ultrastructural sequences of the intracor-
puscular hemoglobin in the sickling process. With Paul-
ing 's h e l p , he was ab le to g ive the a p p r o p r i a t e 
physical/chemical names to the intracorpuscular crystal-
lization of hemoglobin in the sickling red cells. 
As a result, at the April 1950 meeting of the Federation of 
American Societies for Experimental Pathology, Rebuck 
was able to demonstrate the ultrastructural inc ip ient 
crystallization of hemoglobin within the sickle cell. He was 
the first to report this discovery, which had been published 
as an abstract in the March 1950 Federation Proceedings as 
"Sickling processes in anemia and trait erythrocytes with 
the electron microscopy of their incipient crystallization" 
(1). In August 1950, Harris published his confirmatory 
report on tactoid crystallization of reduced sickle hemo-
globin and cited Rebuck's prior work in his introduction. 
As Rebuck pointed out in his original report, incipient 
crystallization took place within the center of the sickle 
ce l l . Further stages of crystal l izat ion resulted in 
anisotropoid angulation of central aggregates followed by 
eccentric massing of the hemoglobin with intense pe-
ripheral spiculation characteristic of aberrant crystalliza-
tion. He concluded that unipolar sickling and filamentation 
arising from one end of the red cell substantiated this 
concept of intracorpuscular crystallization. Although scan-
ning electron microscopy was not yet available, the tri-
dimensional nature of the crystallization inherent in the 
sickle cells was ingeniously demonstrated by applying 
shadow-casting. 
Several years later, in 1955, Rebuck expanded and updated 
this report in a review entitled "Sequential electron micro-
graphy of sickling" published as part of a festschrift by the 
Journal of Laboratory Investigation to honor Dr. Frank 
Hartman (2).* Again, as was always his custom, John 
generously gave credit to his clinical colleagues and medi-
cal technologists for their contributions. 
Two special honors were awarded to Rebuck for his discov-
ery. In 1950, he received the Silver Medal of the American 
Society of Clinical Pathologists for Electron Microscopy in 
Clinical Pathology, and in 1954, he received the First Award 
of the American Academy of Obstetrics and Gynecology 
for Electron Microscopy of the Blood Groups. 
During the 1950s, Rebuck expanded his ultrastructural 
studies using the transmission electron microscope to study 
other blood disorders, especially hereditary elliptocytosis. 
In this instance, Rebuck and his colleagues compared 
human elliptocytes with those from the llama (3). They 
used the electron microscope to show that human ellip-
tocytes were characterized by hemoglobin aggregates at 
either end, making them susceptible to traumatic disrup-
tion, unlike the elliptocytes of the camel family, which 
were actually biconcave ellipses. Although camels were 
not available in Detroit for such studies, John was able to 
use the llamas at the Detroit Zoo to study their elliptical red 
blood cells. Furthermore, while demonstrating that human 
elliptocytes retained their oval outlines after hemolysis, 
which pointed to a membrane fault in this disorder, they 
were not able to hemolyse llama elliptocytes in distilled 
water when the cells were in a 2% suspension. From this 
failure came the important observation that red blood cells 
* Reprinted on pp. 236-44 of this issue. 
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in members of the camel family were able to withstand 
great ranges of plasma hypotonicity and that water stored 
by camels was not, as legend would have it, in their humps, 
but more likely in their elliptical erythrocytes. Again, the 
three dimensional studies were done with the shadow-
casting technique, but Hartsock, years later, using the 
scanning electron microscope, was able to confirm these 
findings for both the llama and man. 
Perhaps Rebuck's greatest scientific contribution, the 
human skin window technique, was introduced in this 
same period. In 1955, his major report in a festschrift 
honoring his teacher Hal Downey was devoted to this 
technique, entitled "A method of studying leukocytic func-
tions in v ivo" (4).* A review of this method and its subse-
quent influence has been written by S. M. Saeed especially 
for this issue and appears on pp. 210-16. Ahead of its time, 
this technique has been a valuable contribution in showing 
functional leukocytic abnormalities in ulcerative colitis, 
diabetes mellitus, allergies, and in monitoring human 
organ transplantation rejection. It is a fitting tribute to its 
lasting importance that the generally accepted designation 
forthis test, even in various medical indices, is the Rebuck 
skin window procedure. 
One revealing example of how Rebuck used his skin 
window technique involves his early (1949) confirmation 
of Hargraves' discovery of the LE cell phenomenon. In-
trigued by a report that several student nurses had acquired 
disseminated lupus erythematosus after they had received 
Dick tests, Rebuck and Lawrence Berman, who had been a 
classmate with John under Hal Downey and who had 
become a hematopathologist at Wayne State University, 
were able to induce LE cell formation in their own skin 
windows by adding serum from patients who had died of 
the disease. Rebuck then presented his findings atthe 1949 
fall meeting of the Central Society for Clinical Research. 
Hargraves himself was in the audience at the time and 
affirmed Rebuck's findings, an important affirmation be-
cause many false claims of LE cell induction were being 
made. In the original report, published the next year (5), 
Rebuck cautioned that once the experiment had been 
successfully completed, it need notbe repeated by transfer-
ring LE plasma into normal individuals, not so much for 
fear of transferring LE in this way but because of the ever-
present danger of transferring the hepatitis virus. It is for this 
reason that John always insisted on having serum transfer 
experiments done on himself. Rebuck, and later Stuart 
Finch of Yale (6), found that skin window testing for LE cells 
in patients with this disorder afforded an extremely sensi-
tive monitor for the severity of the infection: if LE cells 
appeared spontaneously in the test site, the prognosis was 
Reprinted on pp. 184-209. 
especially grave. For his work in this field Rebuck was later 
honored by being named the first Gladys Dick Memorial 
Lecturer at Northwestern University (1968). 
Another example of the usefulness of the skin window 
technique is the work Rebuck did with Robert Priest of the 
Hospital's Gastroenterology Department on patients with 
idiopathic ulcerative colitis (7,8). With an enteric antigen, 
diphtheria toxoid, as the inflammatory agent, Rebuck used 
the skin window technique to reveal a new type of human 
hypersensitivity disorder marked by massive outpourings 
of basophilic leukocytes. Working with the Division of 
Urology at the Hospital, Rebuck next demonstrated the 
same phenomenon in patients suffering from Hunner's 
ulcer and its less destructive form, idiopathic interstitial 
cystitis (9). He noted that the excessive basophilic gran-
ulocytic migrations were accompanied by a parallel tissue 
mast cell hyperplasia, a characteristic ofthe actual lesions 
ofthe colon as shown by Sommers for ulcerative colitis (10) 
and by the Ford Hospital group themselves for Hunner's 
ulcer and interstitial cystitis (9). Although the Danish group, 
headed by Wolf-Jurgensen, were at first reluctant to accept 
the concept of excessive basophil migrations in human 
hypersensitivity states, they later published a confirmatory 
monograph when they found the same basophilic predomi-
nance in the lesions that tested for histoincompatibility 
with the Medawar lymphocyte transfer test (11,12). The 
result of this work was a symposium on basophils and mast 
cells that John organized w i th Jacques Padawer and 
Will iam Simpson for the New York Academy of Sciences in 
1963 and that was later published as a book (13). 
An offshoot of this work with the basophilic granulocytes 
was Rebuck's confirmation of the discovery by Robert 
Good (another Rebuck classmate under Hal Downey) that 
the skin window method was the most accurate diagnostic 
procedure available for identifying the Hunter-Hurler dis-
orders (acid mucopolysaccharidoses) by eliciting easily 
identifiable Hurler cells in the macrophages at the test site 
(14). In turn, this work led to Scheie's use of the skin 
window to identify a forme fruste of Hurler's that bears 
Scheie's name (15,16). Still in pursuit of his understanding 
ofthe "pseudo-mast cells," as he called them, Rebuck next 
obtained purified samples ofal l the known acid mucopoly-
saccharides from Sarah Schiller, who had achieved their 
exacting purification. Together, they published their find-
ings (17) on the induction of Hurler cells by dermatan 
sulfate, the abnormal AMP of the disease itself, in the skin 
windows of Rebuck himself and one of his own resident 
volunteers, Alex Ullman. 
In addition to his pioneering work in discovering and 
developing the skin window technique, Rebuck was also 
instrumental in carrying out work done at Henry Ford 
Hospital in the later 1950s on the ultrastructure of blood 
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platelets (18-22*). This work is discussed in detail by 
Jeanne M. Riddle elsewhere in this issue (pp. 268-75). By 
making use ofthe greater capabilities ofthe electron micro-
scope, Rebuck, Riddle, and I** were able to devise a 
method of categorizing and counting four stages of platelet 
surface activation. Rebuck and his co-workers were among 
the first to adapt this method for evaluating platelet re-
sponses in a variety of disease states. Again, as with his 
work on basophils, the work with platelets culminated in a 
symposium at Henry Ford Hospital on platelets organized 
by the late Shirley Johnson and subsequently published as a 
book (23). 
It would also be remiss not to mention some of John's 
contributions which, although not related to experimenta-
tion in the laboratory, have helped modern medicine just as 
effectively. In the mid-1950s, he assembled most of the 
active hematologists of this country and many from abroad 
for two symposia on leukocytic function and leukemia, the 
first held in New York at the Academy of Sciences and the 
second held here at Henry Ford Hospital (24,25). Beyond 
the importance of the subjects discussed, these meetings 
proved to the participants that the time was propitious for 
establishing an American Society of Hematology. This so-
ciety came into being in 1958 with John as its first secretary, 
a position he held in the first four formative years of the 
society and which, in no small way, has contributed to the 
preeminence this society holds today in American 
medicine. 
In education, Rebuck has also been a leader. Beginning in 
1954, he was one of two pathologists in this country to 
establish a continuing education program in hematology 
for the American Society of Pathologists, long before 
postgraduate medical education was considered manda-
tory. This program has continued up to the present, first 
with myself, then with John's student, the late Joseph 
Sieracki, and presently with S. M. Saeed. Few realize that 
for the last 30 years Rebuck has sent out, through the 
American Society of Pathology, slides of interesting hema-
tology cases to some 1500 laboratories in this country with 
a critique attached that discusses the findings and literature 
pertinent to the problem slide submitted. Rebuck's educa-
tional interests are also reflected in his service on the 
editorial boards of several leading biomedical journals, as 
well as his editorship of the Journal of the Reticuloen-
dothelial Society (1965-74) and of our own HFH Medical 
Journal from 1972 to the present. 
One final facet of Rebuck's varied career deserves com-
ment. Not many of his colleagues are aware of his long-
standing interest in the American space program. When the 
first Russian cosmonaut orbited the earth in 1961, John sent 
him a letter of congratulat ions, and he stil l cherishes 
Gagarin's letter of reply. Unknown for a time to Rebuck 
himself, Werner von Braun planned to use the skin window 
method as early as 1965 to monitor the American astro-
nauts' immunity during the interstellar flight. As a result, in 
1969 Rebuck was asked by the director of the NASA space 
medical program to be the pathology consultant for the 
Apollo lunar landing program, an appointment that led to 
the enthusiastic use of Rebuck's work by the first medical 
astronaut in the Skylab program. 
I am sure I have omitted much that would interest those 
who have followed John's medical career, such as his work 
in the Armed Forces during World War II and his consulta-
tions for them that continue to this day, or his work on the 
Lymphoma Panel and other committees of the National 
Institutes of Health. However, the pages that follow are the 
most fitting testimony to the long and outstanding career of 
this remarkable man. 
— Raymond W. Monto, MD 
Oncology Division 
Henry Ford Hospital 
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